# Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)

Study · id `cardio:ct-nct05617001` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05617001](<https://clinicaltrials.gov/study/NCT05617001>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05617001

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05617001. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-10-04 (actual); primary completion 2024-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05617001, source copy `cardio:ctgov-nct05617001-2024-02-28`, retrieved 2026-10-26)
- Started: 2022-10-04 (actual) (ClinicalTrials.gov record NCT05617001, source copy `cardio:ctgov-nct05617001-2024-02-28`, retrieved 2026-10-26)
- Primary completion: 2024-08 (anticipated) (ClinicalTrials.gov record NCT05617001, source copy `cardio:ctgov-nct05617001-2024-02-28`, retrieved 2026-10-26)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT05617001, source copy `cardio:ctgov-nct05617001-2024-02-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05617001, source copy `cardio:ctgov-nct05617001-2024-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05617001-2024-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)
- Condition: Arrhythmia
- Intervention (Device): Kardia 12L
- Lead sponsor: University of Oklahoma
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: University of Oklahoma (`cardio:org-university-of-oklahoma`)

## Provenance

Content hash: 3e1710dadf3aa4d1b2eddece94a8331eab4135b3734f043f42ce72cdf5b2a50f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
